Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-26

Clinical Trial Update: Efavirenz (EFV) Intensification [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intensification with Efavirenz in people with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

Sponsor: Washington University School of Medicine | Conditions: HIV | Phase 4 | Status: COMPLETED